Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population

Kenneth O Simbiri1, Nicholas A Smith1, Richard Otieno2

  • 1Department of Microbiology and Immunology, Upstate Medical University, Syracuse, New York, United States of America.

Plos One
|May 2, 2015
PubMed

Insights

Genetic variations of Epstein-Barr virus (EBV) strains in Kenya were analyzed using next-generation sequencing. Different EBV types, including EBV-1 and EBV-2, were found to co-exist within the same geographic region.

Area of Science:

  • Virology
  • Genetics
  • Molecular Biology

Background:

  • Epstein-Barr virus (EBV) is linked to Burkitt's lymphoma (BL).
  • Sub-Saharan Africa has endemic BL and harbors both EBV Type 1 (EBV-1) and EBV Type 2 (EBV-2) strains.
  • Limited knowledge exists regarding EBV strain genetic diversity in sub-Saharan Africa.

Purpose of the Study:

  • To investigate the genetic variation of Epstein-Barr virus (EBV) strains in Kenya.
  • To analyze inter- and intra-strain variations within EBV genomes from a specific geographic region.
  • To assess the utility of next-generation sequencing (NGS) for detailed EBV genome analysis.

Main Methods:

  • Generation of spontaneous lymphoblastoid cell lines (LCLs) from Kenyan samples.
  • Polymerase chain reaction (PCR) amplification of the EBV genome.
  • Next-generation sequencing (NGS) for genome sequencing.
  • Phylogenetic and single nucleotide polymorphism (SNP) analyses.

Main Results:

  • Phylogenetic analysis revealed EBV strains related to both EBV-1 and EBV-2.
  • One sample (LCL10) showed closer relation to EBV-2, while three LCLs were closer to EBV-1.
  • SNP analysis indicated clustering of LCL variants.
  • Latent genes (EBNA-1, BLLF1, BPLF1, BRRF2) were found to be less conserved than lytic genes.

Conclusions:

  • Next-generation sequencing (NGS) is effective for detailed analysis of EBV genome variations.
  • Different genetic variations of EBV can coexist within a single geographic area.
  • Further research is needed to understand the implications of co-existing EBV variants.
  • Findings contribute to understanding pathogenic EBV variants in EBV-associated malignancies.

Related Concept Videos